Helen Tobler

2 weeks ago | puffnstuff.com.au | Helen Tobler

And the more hours it’s used per night, the better the outcome, researchers say. Positive airway pressure therapy reduces the likelihood of all-cause and cardiovascular death over five years, researchers say. The systematic review and meta-analysis included randomised controlled trials with more than 1.1 million participants who were mostly male, older and overweight.

3 weeks ago | medicalrepublic.com.au | Helen Tobler

And the more hours it’s used per night, the better the outcome, researchers say. Positive airway pressure therapy reduces the likelihood of all-cause and cardiovascular death over five years, researchers say. The systematic review and meta-analysisincluded randomised controlled trials with more than 1.1 million participants who were mostly male, older and overweight.

4 weeks ago | medicalrepublic.com.au | Helen Tobler

Just five minutes a day is enough. Being advised to do something eccentric every day holds huge appeal to this Back Pager. But while it was tempting to go down a creative track and imagine the wild and flamboyant things that exercise of an eccentric nature might involve, it took just two seconds of research to find out that eccentric exercise means something quite precise: contracting a muscle while it’s lengthening, such as during the downward part of a bicep curl.

1 month ago | medicalrepublic.com.au | Helen Tobler

At best patients will be wasting their money, and there are risks to prescribers too, experts warn. Experts have warned against the practice of microdosing GLP-1 receptor agonists to make a single injector pen last longer, saying patients risk losing clinical benefits, compromising the stability of the medication and wasting their money. Many patients have reportedly reacted to the cost of the popular weight-loss drugs by shrinking their doses to extend the lifespan of one GLP-1 injector.

1 month ago | medicalrepublic.com.au | Helen Tobler

There is a risk of slighly increased blood pressure, it says, but an Australian expert says men should be reassured. The FDA has recommended that boxed warnings relating to increased adverse cardiovascular events be removed from testosterone products.  The recommendations come after the 2023 TRAVERSE trial showed no increased risk of major adverse cardiac events in men who took testosterone for hypogonadism, including in those who had pre-existing or high risk of cardiovascular disease.